MedPath

Clinical observation of moxibustion in the treatment of oligoasthenoteratozoospermia

Early Phase 1
Conditions
oligoasthenoteratozoospermia
Registration Number
ITMCTR2024000093
Lead Sponsor
Yangzhou Hospital of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
Not specified
Inclusion Criteria

(1)1) sperm concentration < 15× 106/ml; Total sperm count < 39× 106/ml; 2) PR < 32% or PR+NP < 40%; 3) Normal sperm morphology < 4%; .
(2) Male between the ages of 22 (inclusive) ~ 40 years old (inclusive).
(3) No male infertility related treatment within two weeks.
(4) Agree to participate in clinical trials and sign informed consent.

Exclusion Criteria

(1) Male infertility caused by congenital malformations of the genital tract or organic diseases of the urinary system such as vas deferens obstruction;
(2) Allergic constitution, known to be allergic to the drug components in this study;
(3) Have serious primary heart, liver, lung, kidney, blood or serious diseases that affect their survival;
(4) According to the judgment of the investigator, there are other pathologies that reduce the possibility of enrollment or complicate enrollment, such as frequent changes in the working environment, which are easy to cause loss to follow-up;
(5) Patients who are participating in clinical trials of other drugs;

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath